Publication: Relative quantitation of mRNA in β-thalassemia/Hb E using real-time polymerase chain reaction
| dc.contributor.author | Watanapokasin Y. | |
| dc.contributor.author | Winichagoon P. | |
| dc.contributor.author | Fuchareon S. | |
| dc.contributor.author | Wilairat P. | |
| dc.date.accessioned | 2021-04-05T04:33:27Z | |
| dc.date.available | 2021-04-05T04:33:27Z | |
| dc.date.issued | 2000 | |
| dc.date.issuedBE | 2543 | |
| dc.description.abstract | β-Thalassemia and Hb E patients, with seemingly identical genotypes, have a remarkable variability in severity. Reduction in red cell survival in β-thalassemia is correlated with the amount of intracellular unmatched α- globin chains. However, it was only recently realized that mRNA, whose translation is prematurely terminated, is also unstable. No systematic attempts have been made to investigate mRNA stability in β-thalassemia arising from nonsense mutations located upstream from the normal termination codon. In this study, one-step real-time polymerase chain reaction has been employed to compare the levels of α- and β-globin mRNA in reticulocytes from β-thalassemia/Hb E subjects. The results showed the highest α/β- globin mRNA ratio (median = 5.70, n = 13) in frameshift codons 41/42 (- TTCT)/Hb E individuals compared to normal subjects (median = 1.02, n = 6), or those with Hb E trait (median = 2.15, n = 8). In addition, there was a concomitant increase in the α/β-globin mRNA ratio with decrease in hemoglobin level, i.e., increase in severity. The difference in the ratio among β-thalassemia/Hb E patients with the same genotype may be attributed to individual variations of efficiency in β(E)-globin mRNA splicing and in the destruction of prematurely terminated mRNA. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Hemoglobin. Vol 24, No.2 (2000), p.105-116 | |
| dc.identifier.doi | 10.3109/03630260009003429 | |
| dc.identifier.issn | 3630269 | |
| dc.identifier.other | 2-s2.0-0034092252 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14740/7051 | |
| dc.rights.holder | Scopus | |
| dc.subject.other | Alpha globin | |
| dc.subject.other | Beta globin | |
| dc.subject.other | Hemoglobin E | |
| dc.subject.other | Messenger RNA | |
| dc.subject.other | Article | |
| dc.subject.other | Beta thalassemia | |
| dc.subject.other | Clinical article | |
| dc.subject.other | Controlled study | |
| dc.subject.other | Disease severity | |
| dc.subject.other | Gene sequence | |
| dc.subject.other | Hemoglobin determination | |
| dc.subject.other | Hemoglobinopathy | |
| dc.subject.other | Human | |
| dc.subject.other | Human cell | |
| dc.subject.other | Pathogenesis | |
| dc.subject.other | Polymerase chain reaction | |
| dc.subject.other | Reticulocyte | |
| dc.subject.other | RNA analysis | |
| dc.subject.other | RNA splicing | |
| dc.title | Relative quantitation of mRNA in β-thalassemia/Hb E using real-time polymerase chain reaction | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034092252&doi=10.3109%2f03630260009003429&partnerID=40&md5=28b5c16a0a40c207ff4cc33ad2cfdffc |
